Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Witzke

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Journal of Allergy and Clinical Immunology|March 1, 1989
Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiencyK Bork, G Witzke
Der Anaesthesist|February 1, 1981
[Haemostatic changes related to extracorporeal circulation (ECC) (author's transl)]G Witzke, O Elert
Der Anaesthesist|July 1, 1979
[Coagulation problems associated with massive blood transfusions. An experimental study (author's transl)]G Witzke, W Abdulla
Thoraxchirurgie, Vaskulare Chirurgie|February 1, 1978
[Experiences on preclotting of vascular dacron protheses with and without addition of factor XIII (author's transl)]U R Kottmann, G Witzke
MMW, Munchener Medizinische Wochenschrift|August 10, 1979
[Recommendations for transfusion therapy. Volume substitution, raising oxygen transport capacity and replacement of clotting factors (author's transl)]W Abdulla, R Frey, G Witzke
Allergy|December 2, 2016
Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII)K Bork, K Wulff, G Witzke, et al.
Allergy|May 9, 2015
Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutationsK Bork, K Wulff, G Witzke, et al.
Klinische Wochenschrift|November 15, 1983
Hereditary angioneurotic oedema and blood-coagulation: interaction between C1-esterase-inhibitor and the activation factors of the proteolytic enzyme systemsG Witzke, K Bork, P Benes, et al.
Klinische Wochenschrift|December 17, 1984
Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80M Reitz, G Witzke, R Egbring, et al.
Archives of Dermatological Research|January 1, 1984
Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticariaK Bork, G Witzke, K Artmann, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Allergy and Clinical Immunology|March 1, 1989
Long-term prophylaxis with C1-inhibitor (C1 INH) concentrate in patients with recurrent angioedema caused by hereditary and acquired C1-inhibitor deficiencyK Bork, G Witzke
Der Anaesthesist|February 1, 1981
[Haemostatic changes related to extracorporeal circulation (ECC) (author's transl)]G Witzke, O Elert
Der Anaesthesist|July 1, 1979
[Coagulation problems associated with massive blood transfusions. An experimental study (author's transl)]G Witzke, W Abdulla
Thoraxchirurgie, Vaskulare Chirurgie|February 1, 1978
[Experiences on preclotting of vascular dacron protheses with and without addition of factor XIII (author's transl)]U R Kottmann, G Witzke
MMW, Munchener Medizinische Wochenschrift|August 10, 1979
[Recommendations for transfusion therapy. Volume substitution, raising oxygen transport capacity and replacement of clotting factors (author's transl)]W Abdulla, R Frey, G Witzke
Allergy|December 2, 2016
Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII)K Bork, K Wulff, G Witzke, et al.
Allergy|May 9, 2015
Hereditary angioedema with normal C1-INH with versus without specific F12 gene mutationsK Bork, K Wulff, G Witzke, et al.
Klinische Wochenschrift|November 15, 1983
Hereditary angioneurotic oedema and blood-coagulation: interaction between C1-esterase-inhibitor and the activation factors of the proteolytic enzyme systemsG Witzke, K Bork, P Benes, et al.
Klinische Wochenschrift|December 17, 1984
Coagulation factors and proteinase inhibitors in the plasma of children with acute lymphoblastic leukoses. Behaviour before and during treatment according to Protocol I of the Cooperative Leukaemia Study COALL-80M Reitz, G Witzke, R Egbring, et al.
Archives of Dermatological Research|January 1, 1984
Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticariaK Bork, G Witzke, K Artmann, et al.
Pageof 2